We had mentioned in Wednesday’s closing report that Nifty, Sensex were on a rising trend. On Thursday, the major indices rallied today. On the NSE, there were 1,038 advances, 776 declines and 346 unchanged.
The trends of the major indices in the course of Wednesday’s trading are given in the table below:
Dilip Buildcon received letter of acceptance for a Rs 4,167.70-crore EPC project in Gujarat. The project includes engineering, procurement and construction contract for Bhadbhut barrage, flood protection embankments and associated works across the river Narmada near village Bhadbhut in Bharuch district.
Rossari Biotech stock jumped 12% on debut. It listed with a whopping 57.65 percent premium over its IPO price on July 23. Rossari Biotech raised Rs 496 crore through public issue during July 13-15. The issue consisted of Rs 50 crore fresh issue and the balance funds went to promoters.
SpiceJet was declared as Indian scheduled carrier to operate on agreed services between India and the United States of America.
PNB Housing Finance posted 9.5% YoY fall in consolidated net profit at Rs 257 crore for the June quarter versus Rs 284 crore in the previous year. Revenue went down 16.2% to Rs 1,870 crore.
Cadila Healthcare’s Zydus received the US drug regulator's nod to initiate clinical trials for Desidustat in cancer patients receiving chemotherapy. Zydus has also initiated a Phase II(b) trial of Desidustat in Mexico for the management of patients with COVID-19.
Future Retail missed paying USD 14 million (about Rs105 crore) in interest dues on July 22 on its offshore bonds worth USD 500 million due in 2025.
Balaji Telefilms narrowed losses to Rs 19.84 crore in the quarter ended March 31, 2020. The company had posted consolidated loss of Rs 27.97 crore in the same quarter of the previous fiscal. Balaji Telefilms has resumed shoot for all its television shows from July 16.
Bank of Maharashtra reported 24% YoY rise in net profits for the quarter ended June at Rs.101.26 crore. Revenues grew 2.28% YoY to Rs.3,265 crore.
Lupin has received tentative approval for its Empagliflozin and Linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg, from the United States Food and Drug Administration (U.S. FDA).
HDFC Life plans to raise Rs.600 crore through issue of non-convertible debentures on a private placement basis.
The top gainers and top losers of the major indices are given in the table below:
The closing values of the major Asian indices are given in the table below: